Sex hormone-induced mammary carcinogenesis in female noble rats: the role of androgens.

Breast cancer is the most common cancer and the second most frequent cause of cancer death in women. Despite extensive research, the precise mechanisms of breast carcinogenesis remain unclear. We have shown that in female rats, treatment with a combination of oestrogen and testosterone can induce a high incidence of mammary cancer. The dosage of testosterone affects only the latency period of mammary cancer, not the final incidence. Based on these observations, we hypothesize that oestrogen and androgens may act in concert on the mammary gland to induce mammary carcinogenesis, with oestrogen serving as the predominant initiator whereas the androgen acts as a major promoter. In the present study, we report the changes in morphology of the mammary gland with special emphasis on the perialveolar or interlobular stroma after treatment with various sex hormone protocols. Our data showed that after treatment with testosterone, either alone or in combination with 17beta-oestradiol, there was overexpression of the androgen receptor in alveolar or ductal epithelial cells. Concurrent with strong expression of the androgen receptor in epithelium, there was also an increase in the amount of perialveolar and interlobular connective tissue, a decrease in surrounding adipose tissue and an increase in proliferation rate of fibroblast-like cells in the stroma. All these changes were blocked by simultaneous implantation of flutamide, indicating that androgens play a crucial role in the process despite the absence of androgen receptors in stromal cells. We further measured the mammary gland density (MGD), in order to determine the ratio of fatty to non-fatty tissue. The data showed that MGD values were significantly higher in animals treated with testosterone alone or in combination with 17beta-oestradiol than in those treated with 17beta-oestradiol alone or in controls. Furthermore, treatment with different doses of testosterone resulted in an increase in MGD in a dose-dependent manner. These findings highlight the effect of androgens on the stroma, probably through a paracrine action of epithelial cells. The stroma may, in turn, promote mammary carcinogenesis in a reciprocal fashion.

[1]  P. Rosen Rosen's Breast Pathology , 2001 .

[2]  S. Tsao,et al.  Induction of high incidence of mammary tumour in female Noble rats with a combination of 17beta-oestradiol and testosterone. , 1999, Carcinogenesis.

[3]  B. Xie,et al.  Induction of breast cancer in Noble rats with a combination of estrogen and testosterone , 1999 .

[4]  X. Hou,et al.  Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors. , 1998, Carcinogenesis.

[5]  M. Wang,et al.  The transcriptional effects and DNA-binding specificities of 17beta-estradiol after dimethyldioxirane activation. , 1998, Carcinogenesis.

[6]  Y. Wong,et al.  Sex hormone‐induced prostatic carcinogenesis in the Noble rat: The role of insulin‐like growth factor‐1 (IGF‐1) and vascular endothelial growth factor (VEGF) in the development of prostate cancer , 1998, The Prostate.

[7]  S. Heymsfield,et al.  Six-compartment body composition model: Inter-method comparisons of total body fat measurement , 1998, International Journal of Obesity.

[8]  A. Conney,et al.  Functional role of estrogen metabolism in target cells: review and perspectives. , 1998, Carcinogenesis.

[9]  S. Heymsfield,et al.  Density of fat-free body mass: relationship with race, age, and level of body fatness. , 1997, The American journal of physiology.

[10]  S. Hayward,et al.  Stromal-epithelial interactions in the normal and neoplastic prostate. , 1997, British journal of urology.

[11]  C. Longcope,et al.  Serum sex hormone levels are related to breast cancer risk in postmenopausal women. , 1997, Environmental health perspectives.

[12]  D. Roy,et al.  Profound effects of the weak environmental estrogen-like chemical bisphenol A on the growth of the mammary gland of Noble rats , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  P. Wingo,et al.  Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.

[14]  S. Schnitt,et al.  Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. , 1996, Journal of the National Cancer Institute.

[15]  R. Dahiya,et al.  Smooth muscle-epithelial interactions in normal and neoplastic prostatic development. , 1996, Acta anatomica.

[16]  F Berrino,et al.  Serum sex hormone levels after menopause and subsequent breast cancer. , 1996, Journal of the National Cancer Institute.

[17]  Yager Jd,et al.  Molecular Mechanisms of Estrogen Carcinogenesis , 1996 .

[18]  M J Bissell,et al.  Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.

[19]  T. Maudelonde,et al.  Hormonal Carcinogenesis V , 1996 .

[20]  R. Dickson,et al.  Growth factors in breast cancer. , 1995, Endocrine reviews.

[21]  M. Sporn,et al.  Transforming growth factor-beta s in mammary tumorigenesis: promoters or antipromoters? , 1995, Progress in clinical and biological research.

[22]  T. H. van der Kwast,et al.  Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in routinely processed, paraffin-embedded human tissues after microwave pre-treatment. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[23]  G. Cunha Role of mesenchymal‐epithelial interactions in normal and abnormal development of the mammary gland and prostate , 1994, Cancer.

[24]  H. Sasano,et al.  Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[25]  F. Bosman,et al.  Epithelial-stromal interactions in colon cancer. , 1993, The International journal of developmental biology.

[26]  J. Kelsey Breast cancer epidemiology: summary and future directions. , 1993, Epidemiologic reviews.

[27]  J. Taylor‐Papadimitriou,et al.  Human models of breast cancer. , 1993, Cancer surveys.

[28]  P. Yaswen,et al.  Culture systems for study of human mammary epithelial cell proliferation, differentiation and transformation. , 1993, Cancer surveys.

[29]  L. Bernstein,et al.  Endogenous hormones and breast cancer risk. , 1993, Epidemiologic reviews.

[30]  P. Johnston,et al.  Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line. , 1992, Cancer research.

[31]  J. Varhaug,et al.  Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. , 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[32]  T. H. van der Kwast,et al.  Androgen receptor expression in human tissues: an immunohistochemical study. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[33]  F. Berrino,et al.  Serum and urinary androgens and risk of breast cancer in postmenopausal women. , 1991, Cancer research.

[34]  T. Thorsen,et al.  Improved measurement of androgen receptors in human breast cancer. , 1989, Cancer research.

[35]  A. van den Hooff,et al.  Stromal involvement in malignant growth. , 1988 .

[36]  R. Dickson,et al.  Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. , 1987, Endocrine reviews.

[37]  J. Drife Breast Development in Puberty , 1986, Annals of the New York Academy of Sciences.

[38]  F. Kasumi,et al.  Plasma testosterone and breast cancer. , 1985, European journal of cancer & clinical oncology.

[39]  R. Bryan,et al.  Androgen receptors in breast cancer , 1984, Cancer.

[40]  F. Berrino,et al.  Increased androgenic activity and breast cancer risk in premenopausal women. , 1984, Cancer research.

[41]  H. Rochefort,et al.  The estrogenic and antiestrogenic activities of androgens in female target tissues. , 1983, Pharmacology & therapeutics.

[42]  G. Tremblay Stromal aspects of breast carcinoma. , 1979, Experimental and molecular pathology.

[43]  W. McGuire,et al.  Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. , 1978, The Journal of biological chemistry.

[44]  U. Veronesi,et al.  Breast cancer in women subsequent to cystic disease of the breast. , 1968, Surgery, gynecology & obstetrics.

[45]  Noble Rl,et al.  ESTRONE-INDUCED MAMMARY TUMORS IN THE RAT. I. INDUCTION AND BEHAVIOR OF TUMORS. , 1964 .

[46]  J. Cutts Estrone-induced Mammary Tumors in the Rat II. Effect of Alterations in the Hormonal Environment on Tumor Induction, Behavior, and Growth , 1964 .